Insider · CIK 0001532233
Brian Bernick
Files at TXMD (TherapeuticsMD, Inc.). First filing Dec 9, 2022, latest Dec 9, 2022.
In brief
Brian Bernick files SEC Form 4 as CEO at TXMD (TherapeuticsMD, Inc.). Since Dec 9, 2022, Brian Bernick has reported 0 open-market buys worth $0 and 1 open-market sell worth $6,621, the latest filed on Dec 9, 2022.
A track record needs three past buys with six months of prices behind them; Brian Bernick has 0, so none is measured yet.
The newest scored trade: sold $6,621 of TXMD on Dec 6, 2022, filed Dec 9, 2022, scored 30 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
TXMD: TherapeuticsMD, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | TherapeuticsMD, Inc. | $6,621 1,255 shares | -24% | +161% from low-77% from high |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 6, 2022 | TXMD TherapeuticsMD, Inc. | MOption exercise Common Stock | +3,167 | $0.00 | $0 | 5,127 | Dec 9, 2022 |
| Dec 6, 2022 | TXMD TherapeuticsMD, Inc. | SOpen-market sale Common Stock | -935 | $4.92 | $4,602 | 4,192 | Dec 9, 2022 |
| Dec 9, 2022 | TXMD TherapeuticsMD, Inc. | SOpen-market sale Common Stock | -320 | $6.31 | $2,020 | 3,872 | Dec 9, 2022 |
| Dec 6, 2022 | TXMD TherapeuticsMD, Inc. | MOption exercise Restricted Stock Unitsderivative | -3,167 | $0.00 | $0 | 10,517 | Dec 9, 2022 |
Questions about Brian Bernick
Answered from the filings on this page, as of the latest one.
Is Brian Bernick buying or selling?
Not in the last 12 months. Brian Bernick's latest open-market trade on SEC Form 4 was sold $6,621 of TXMD on Dec 6, 2022.
How did Brian Bernick's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Brian Bernick has 0.
Where does Brian Bernick file Form 4?
Brian Bernick has filed Form 4 at TXMD (TherapeuticsMD, Inc.) as Co-Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.